# US 2022/0068453 A1 · System and method for monitoring a therapeutic treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0068453 A1
- Document ID: US20220068453A1
- Status: Published application
- Kind: A1
- Application number: 17/454,525
- Filed: 2021-11-11
- Published: 2022-03-03
- Earliest claimed: 2015-05-07
- Assignees: DexCom, Inc.
- Applicants: DexCom, Inc.
- Inventors: Peter C. Simpson
- Web page: https://patentgrep.com/patent/US20220068453A1

## CPC

- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- A61B 5/0022: {Monitoring a patient using a global network, e.g. telephone networks, internet}
- A61B 5/0077: {Devices for viewing the surface of the body, e.g. camera, magnifying lens}
- A61B 5/1112: {Global tracking of patients, e.g. by using GPS}
- A61B 5/1118: {Determining activity level}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/1495: Calibrating or testing of in-vivo probes
- A61B 5/4833: {Assessment of subject's compliance to treatment}
- A61B 5/486: {Biofeedback (using electroencephalography [EEG] A61B5/375)}
- A61B 5/4866: {Evaluating metabolism (using breath test A61B5/083)}
- A61B 5/4872: {Body fat}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- A61B 5/7435: {Displaying user selection data, e.g. icons in a graphical user interface}
- A61B 5/7475: {User input or interface means, e.g. keyboard, pointing device, joystick}
- G09B 19/00: Teaching not covered by other main groups of this subclass (teaching or practice apparatus for gun-aiming or gun-laying F41G3/26)
- G09B 19/0092: {Nutrition}
- G16H 10/20: for electronic clinical trials or questionnaires
- G16H 20/70: relating to mental therapies, e.g. psychological therapy or autogenous training
- G16H 40/40: for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
- G16H 40/63: for local operation
- G16H 40/67: for remote operation
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- A61B 2562/0219: Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
- G16H 15/00: ICT specially adapted for medical reports, e.g. generation or transmission thereof
- G16H 20/30: relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
- G16H 20/40: relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
- G16H 20/60: relating to nutrition control, e.g. diets
- G16H 50/50: for simulation or modelling of medical disorders
- Y02A 90/10: Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G09B: EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS (devices for psychotechnics or for testing reaction times A61B5/16; games, sports, amusements A63; projectors, projector screens G03B)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Provided are systems and methods for monitoring a therapeutic treatment such as a treatment for diabetes, for example. In accordance with the method, a program that a user is to comply with is selected. The program includes adherence to a medication and/or food regimen. An additive incorporated in the medication and/or the food ingested by the user as a part of the program is monitored in real time. Compliance with the program is evaluated based at least in part on the monitoring of the additive.

## Claims

### Claim 1

A method for monitoring a therapeutic treatment, comprising:
selecting a program that a user is to comply with, the program including adherence to a medication and/or food regimen;
monitoring in real time an additive incorporated in the medication and/or the food ingested by the user as a part of the program; and
evaluating compliance with the program based at least in part on the monitoring of the additive.

### Claim 2 (depends on 1)

The method of claim 1 further comprising displaying an output responsive to the evaluating.

### Claim 3 (depends on 2)

The method of claim 2 wherein the output indicates a degree of success or failure of the program.

### Claim 4 (depends on 1)

The method of claim 1 further comprising modifying the program based at least in part on the evaluating.

### Claim 5 (depends on 3)

The method of claim 3 wherein the modifying is further based at least in part on evaluating data about other users having a profile similar to the user.

### Claim 6 (depends on 4)

The method of claim 4 further comprising monitoring in real time an analyte level, wherein the modifying is further based at least in part on the monitored analyte level.

### Claim 7 (depends on 6)

The method of claim 6 wherein the monitoring of the additive and the monitoring of the analyte level are performed by different sensors.

### Claim 8 (depends on 6)

The method of claim 6 wherein the monitoring of the additive and the monitoring of the analyte level are performed by a common sensor.

### Claim 9 (depends on 1)

The method of claim 1 further comprising communicating an output responsive to the evaluating to a third party.

### Claim 10 (depends on 9)

The method of claim 9 wherein the third party includes a pharmacy, clinician and/or a case manager.

### Claim 11 (depends on 1)

The method of claim 1 wherein the therapeutic treatment includes therapeutic treatment of diabetes.

### Claim 12 (depends on 4)

The method of claim 4 wherein the therapeutic treatment includes therapeutic treatment for weight loss.

### Claim 13 (depends on 4)

The method of claim 4 wherein modifying the program is further based at least in part on data exclusive of sensor data.

### Claim 14 (depends on 13)

The method of claim 13 wherein the data exclusive of sensor data includes information specifying therapeutic treatments previously used by the user.

### Claim 15 (depends on 14)

The method of claim 14 wherein the data exclusive of sensor data includes user-entered information.

### Claim 16 (depends on 1)

The method of claim 1 wherein evaluating compliance with the program includes evaluating compliance with a type and dosage of the medication and/or food.

### Claim 17 (depends on 1)

The method of claim 1 wherein evaluating compliance with the program is also based at least in part on additional data.

### Claim 18 (depends on 17)

The method of claim 17 wherein the additional data includes manually entered data, sensor data and/or cloud-based data.

### Claim 19 (depends on 2)

The method of claim 2 wherein the output indicates a potential overdose or misuse of the medication.

### Claim 20 (depends on 1)

The method of claim 1 wherein the additive includes an aptamer that is monitored.

### Claim 21 (depends on 2)

The method of claim 2 wherein the output indicates a frequency of use of the medication and/or food.

### Claim 22 (depends on 2)

The method of claim 2 wherein the output indicates an amount of the medication and/or food in the body over time.

### Claim 23 (depends on 2)

The method of claim 2 wherein the output indicates a metabolic rate of the user.

### Claim 24 (depends on 2)

The method of claim 2 wherein the output indicates a correlation between a degree of compliance with the program and another analyte being monitored.

### Claim 25 (depends on 2)

The method of claim 2 wherein the output indicates a correlation between a degree of compliance with the program and a physiological result to be achieved.

### Claim 26 (depends on 2)

The method of claim 2 wherein the additive includes an electronic chip generating electrical signals that are monitored.
